Name: Hepatitis b Virus, an Issue of Clinics in Liver Disease (Volume 23-2) (The Clinics: Internal Medicine, Volume 23-2) (en Inglés)
Price: 1393.63 MXN
Availability: InStock
Author: Tarek I. Hassanein Md
ISBN: 9780323682282

Envío gratis

portada Hepatitis b Virus, an Issue of Clinics in Liver Disease (Volume 23-2) (The Clinics: Internal Medicine, Volume 23-2) (en Inglés)

Formato

Libro Físico

Editorial

Elsevier

Autor

Tarek I. Hassanein Md

Idioma

Inglés

Encuadernación

Tapa Dura

ISBN13

9780323682282

N° edición

Hepatitis b Virus, an Issue of Clinics in Liver Disease (Volume 23-2) (The Clinics: Internal Medicine, Volume 23-2) (en Inglés)

Tarek I. Hassanein Md (Autor) · Elsevier · Tapa Dura

Libro Nuevo

$ 1,393.63

$ 2,787.27

Ahorras: $ 1,393.63

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 13 de Junio y el Martes 25 de Junio.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Hepatitis b Virus, an Issue of Clinics in Liver Disease (Volume 23-2) (The Clinics: Internal Medicine, Volume 23-2) (en Inglés)"

In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Tarek Hassanein has assembled top experts in hepatology to bring current information on the topic of Hepatitis B Virus. The issue provides the most current information on the prevention and care of infected patients. Specific articles are devoted to the following topics: Global perspective on HBV infections in the era of effective vaccines; Understanding the natural history of HBV infection and the new definitions of cure and the endpoints of clinical trials; HBV/HCV coinfection in the era of HCV-DAAs; Antiretroviral effects on HBV/HIV coinfection and the natural history of liver disease; Impact of HBV infection on HCC and liver transplantation; HBV in pregnant women and their infants; WHO guidelines for prevention, care and treatment of individuals infected with HBV: A US perspective; Reconciling the difference between the major HBV treatment guidelines: AASLD, EASL, APASL; HBV/HDV coinfection: A challenge for therapeutics; and The effects of hepatic steatosis on the natural history of HBV infection. Readers will come away with the current information they need to manage patient outcomes.